Active ingredient
Revumenib
3 finished FDA listings contain Revumenib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- REVUMENIB CITRATE
- Dosage forms
- Tablet, Film Coated
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 110 mg/1 · 160 mg/1 · 25 mg/1
- Brand names in FDA listings
- Revuforj
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2698325
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 218944 | SYNDAX | 2024-11-15 | 3 |
Official labeling on DailyMed
- REVUFORJ (REVUMENIB) TABLET, FILM COATED [SYNDAX PHARMACEUTICALS, INC.] · version 5 · 2026-02-20
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.